November 5, 2018 / 5:40 PM / 12 days ago

BRIEF-Corrected-Novartis CFO Says - Expects Research And Development Costs To Decline Over Time To Around 20 Percent Of Sales

Nov 5 (Reuters) - Novartis AG:

* NOVARTIS CFO SAYS - EXPECTS RESEARCH AND DEVELOPMENT COSTS TO DECLINE OVER TIME TO AROUND 20 PERCENT OF SALES Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below